See more : Gracell Biotechnologies Inc. (GRCL) Income Statement Analysis – Financial Results
Complete financial analysis of Rose Hill Acquisition Corporation (ROSE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rose Hill Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- XIANGPIAOPIAO Food Co.,Ltd (603711.SS) Income Statement Analysis – Financial Results
- Cronos Australia Limited (CAU.AX) Income Statement Analysis – Financial Results
- American Coastal Insurance Corporation (ACIC) Income Statement Analysis – Financial Results
- PT Bekasi Asri Pemula Tbk (BAPA.JK) Income Statement Analysis – Financial Results
- Lloyds Engineering Works Limited (LLOYDSENGG.NS) Income Statement Analysis – Financial Results
Rose Hill Acquisition Corporation (ROSE)
About Rose Hill Acquisition Corporation
Rose Hill Acquisition Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar combination with one or more businesses or assets. It intends to focus on companies that operate in Latin American markets. The company was incorporated in 2021 and is based in Atlanta, Georgia.
| Metric | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 302.28M | 301.88M | 76.24M | 0.00 |
| Cost of Revenue | 0.00 | 550.50K | 181.04M | 185.76M | 49.95M | 0.00 |
| Gross Profit | 0.00 | -550.50K | 121.24M | 116.11M | 26.29M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 40.11% | 38.46% | 34.48% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.11M | 69.86 | 35.73M | 30.47M | 16.05M | 1.64M |
| Selling & Marketing | 0.00 | 40.71 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.11M | 110.56 | 35.73M | 30.47M | 16.05M | 1.64M |
| Other Expenses | 0.00 | 0.00 | 33.35M | 18.88M | 5.28M | 0.00 |
| Operating Expenses | 1.11M | 3.10K | 69.08M | 49.35M | 21.33M | 1.64M |
| Cost & Expenses | 1.11M | 3.10K | 250.12M | 235.11M | 71.28M | 1.64M |
| Interest Income | 2.12M | 0.00 | 0.00 | 0.00 | 0.00 | 196.81K |
| Interest Expense | 0.00 | 0.00 | 25.23M | 19.49M | 2.53M | 196.81K |
| Depreciation & Amortization | -5.20M | 6.16M | -16.38M | 28.93M | 6.13M | 393.62K |
| EBITDA | -6.31M | 3.41K | 35.79M | 95.69M | 26.73M | -1.24M |
| EBITDA Ratio | 0.00% | 0.00% | 11.84% | 31.70% | 14.54% | 0.00% |
| Operating Income | -1.11M | -305.98 | 52.16M | 66.76M | 4.96M | -1.64M |
| Operating Income Ratio | 0.00% | 0.00% | 17.26% | 22.12% | 6.51% | 0.00% |
| Total Other Income/Expenses | 7.32M | 3.41K | -80.11M | 69.36M | -15.22M | 196.81K |
| Income Before Tax | 6.21M | 3.10K | -27.95M | 136.12M | -10.26M | -1.44M |
| Income Before Tax Ratio | 0.00% | 0.00% | -9.24% | 45.09% | -13.46% | 0.00% |
| Income Tax Expense | -7.32M | -6.16M | 2.14M | 18.16M | 1.69M | 0.00 |
| Net Income | 13.53M | 3.10K | 8.42M | 58.04M | 6.86M | -1.44M |
| Net Income Ratio | 0.00% | 0.00% | 2.78% | 19.23% | 9.00% | 0.00% |
| EPS | 0.94 | 0.42 | 0.58 | 1.25 | 1.15 | -0.55 |
| EPS Diluted | 0.94 | 0.42 | 0.58 | 1.25 | 1.15 | -0.55 |
| Weighted Avg Shares Out | 14.38M | 7.36K | 14.48M | 46.50M | 5.95M | 2.63M |
| Weighted Avg Shares Out (Dil) | 14.38M | 7.36K | 14.48M | 46.50M | 5.95M | 2.63M |
Source: https://incomestatements.info
Category: Stock Reports